Kids & Company

Prioritize health for you and your family with Medcan

A Proactive Approach to Your Health

Medcan is a global leader in proactive health and wellness services devoted to providing care that is grounded in the latest evidence-based practices, technologies and treatments. We are proud to partner with them to offer you proactive health solutions to empower you to live well, for life. Learn more below or complete the form to book an appointment for Medcan services.

You
are
eligible
for
preferred
rates

As a Kids & Company client, you benefit from preferred rates on a suite of Medcan services and a dedicated contact for your personal inquiries.

Enjoy 15% off Medcan's flagship Annual Health Assessment, a full-body physician-led health evaluation, as well as Year-Round Care Memberships for you and your family, and the Galleri® multi-cancer early detection test. You also receive 10% off our Dedicated Care membership. Please see below for more details on these eligible services.

A professional man standing with his doctor, both smiling, reviewing chart

Services
Offered

You are eligible for preferred rates on the following Medcan services:

  • Galleri is a registered trademark of GRAIL, Inc.  *The Galleri test does not detect a signal for all cancers. Not all cancers can be detected in the blood. False positive and false negative results do occur. 1 in 100 can expect to receive a CSD result, and approximately 60% of these individuals will receive a confirmed cancer diagnosis. The overall sensitivity in study participants with head and neck cancer was 85.7% (63.2% for stage I, 82.4% stage II, 84.2% stage III, 96.0% stage IV).    **Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer. The Galleri test is not a genetic risk assessment and does not predict future genetic risk for cancer. The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false/negative results do occur. Galleri should be used in addition to healthcare provider recommended screening tests. Important Safety Information: The Galleri test is recommended for use in adults with an elevated risk for cancer, such as those age 50 or older. The test does not detect all cancers and should be used in addition to routine cancer screening tests recommended by a healthcare provider. The Galleri test is intended to detect cancer signals and predict where in the body the cancer signal is located. Use of the test is not recommended in individuals who are pregnant, 21 years old or younger, or undergoing active cancer treatment. Results should be interpreted by a healthcare provider in the context of medical history, clinical signs, and symptoms. A test result of No Cancer Signal Detected does not rule out cancer. A test result of Cancer Signal Detected requires confirmatory diagnostic evaluation by medically established procedures (e.g., imaging) to confirm cancer. If cancer is not confirmed with further testing, it could mean that cancer is not present or testing was insufficient to detect cancer, including due to the cancer being located in a different part of the body. False positive (a cancer signal detected when cancer is not present) and false negative (a cancer signal not detected when cancer is present) test results do occur. Lab / Test information: The GRAIL clinical laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) and accredited by the College of American Pathologists. The Galleri test was developed and its performance characteristics were determined by GRAIL. The Galleri test has not been cleared or approved by the Food and Drug Administration. This test is not Health Canada or FDA approved, and has not been endorsed by any professional medical societies at this time. The GRAIL clinical laboratory is regulated under CLIA to perform high-complexity testing. The Galleri test is intended for clinical purposes.